ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,919Medicare Part D Prescriptions Filled, Including Refills

Rank: 172 out of 617

$333K Total Retail Price of All Prescriptions

Rank: 203 out of 617

534 Patients Receiving at Least One Drug in Part D
78%Patients 65 Years and Older
49% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nebraska
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 534 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

10% of this provider’s 534 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

2% of this provider’s 5,931 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$42 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

15 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nebraska
OMEPRAZOLE 322 236 1 3
LEVOTHYROXINE SODIUM 318 265 2 1
MELOXICAM 300 234 3 24
SIMVASTATIN 296 237 4 2
LISINOPRIL 233 174 5 5
FUROSEMIDE 206 176 6 4
WARFARIN SODIUM 202 181 7 7
HYDROCODONE-ACETAMINOPHEN 168 79 S3 8 8
METOPROLOL TARTRATE 165 153 9 11
METFORMIN HCL 153 119 10 9
CARVEDILOL 142 132 11 19
GABAPENTIN 132 97 12 16
AMLODIPINE BESYLATE 126 97 13 6
POTASSIUM CHLORIDE 113 77 14 10
METOPROLOL SUCCINATE 109 95 15 12
SERTRALINE HCL 107 72 16 20
POLYETHYLENE GLYCOL 3350 106 100 17 32
ATORVASTATIN CALCIUM 102 78 18 14
FLUTICASONE PROPIONATE 101 68 19 36
CITALOPRAM HBR 88 48 20 18
AMITRIPTYLINE HCL 86 38 R 21 56
HYDROCHLOROTHIAZIDE 81 61 22 13
TRAMADOL HCL 77 58 23 15
ALLOPURINOL 72 65 24 27
PREDNISONE 72 49 24 31
RANITIDINE HCL 63 34 26 40
VESICARE 62 55 27 95
PANTOPRAZOLE SODIUM 61 50 28 37
PAROXETINE HCL 61 60 28 62
ZOLPIDEM TARTRATE 56 38 30 23
LEVOFLOXACIN 56 39 30 89
TAMSULOSIN HCL 56 38 30 26
RISPERIDONE 53 48 33 71
CIPROFLOXACIN HCL 52 41 34 60
TOPIRAMATE 50 13 35 149
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 9, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.